Annual Drug Patent Expiration for EPRONTIA
Eprontia is a drug marketed by Azurity and included in one NDA. It is available from a single supplier. There is one patent protecting this drug.
Trends in prices for EPRONTIA drugs.
The generic ingredient in EPRONTIA is topiramate. One registered supplier for this compound. Additional details are available on the topiramate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the Azurity drug EPRONTIA